All Stories

  1. Levels of plasma 25-hydroxy vitamin D and risk of developing type 2 diabetes in a large Danish primary health care population
  2. Diurnal fluctuations in biochemical parameters related to calcium homeostasis – the Bispebjerg study of diurnal variations
  3. Development of an App for Symptom Management in Women With Breast Cancer Receiving Maintenance Aromatase Inhibitors: Protocol for a Mixed Methods Feasibility Study
  4. Measurement of plasma total calcium before plasma free ionized calcium – a possibility with affordable pitfalls
  5. Psychological impairment in inflammatory bowel diseases: the key role of coping and defense mechanisms
  6. Single zoledronic acid infusion as a cause of acute kidney impairment requiring dialysis in two patients with osteoporosis
  7. Development of an App for Symptom Management in Women With Breast Cancer Receiving Maintenance Aromatase Inhibitors: Protocol for a Mixed Methods Feasibility Study (Preprint)
  8. Peripheral blood mononuclear cells exhibit increased mitochondrial respiration after adjuvant chemo- and radiotherapy for early breast cancer
  9. Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report
  10. Weight Change in Post-Menopausal Women with Breast Cancer during Chemotherapy—Perspectives on Nutrition, Activity and Bone Metabolism: An Interim Analysis of a 5-Year Prospective Cohort
  11. Anxiety Levels Predict Bone Mineral Density in Postmenopausal Women Undergoing Oral Bisphosphonates: A Two-Year Follow-Up
  12. RANKL regulates male reproductive function
  13. Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial
  14. Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer
  15. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
  16. Vitamin D levels and cancer incidence in 217,244 individuals from primary health care in Denmark
  17. Effect of chemotherapy and aromatase inhibitors in the adjuvant treatment of breast cancer on glucose and insulin metabolism-A systematic review
  18. Chronic Non-bacterial Osteomyelitis: A Review
  19. The association of celiac disease and allergic disease in a general adult population
  20. FRAX Calculated without BMD Resulting in a Higher Fracture Risk Than That Calculated with BMD
  21. Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab: a case report
  22. Identification and Functional Characterization of a Novel Mutation in the Human Calcium-Sensing Receptor That Co-Segregates With Autosomal-Dominant Hypocalcemia
  23. Modulation of the sympathetic nervous system in youngsters by vitamin-D supplementation
  24. The role of the P2X7 receptor on bone loss in a mouse model of inflammation-mediated osteoporosis
  25. P2Y12 Receptor Antagonist, Clopidogrel, Does Not Contribute to Risk of Osteoporotic Fractures in Stroke Patients
  26. Evidence for the prevention of bone loss in elderly and old early non-metastatic breast cancer patients treated with aromatase inhibitors
  27. Erratum to: determinants of vitamin D status in young adults: influence of lifestyle, sociodemographic and anthropometric factors
  28. P2X7Rs are involved in cell death, growth and cellular signaling in primary human osteoblasts
  29. Letter to the Editor Response: The J-shaped 25-hydroxyvitamin D concentration/CVD-mortality relation is an artifact caused by lack of correction due to age, by Steen Ahrenkiel
  30. Determinants of vitamin D status in young adults: influence of lifestyle, sociodemographic and anthropometric factors
  31. Physical exercise associated with improved BMD independently of sex and vitamin D levels in young adults
  32. Real-Life and RCT Participants: Alendronate Users Versus FITs’ Trial Eligibility Criterion
  33. Vertebral fracture assessment by DXA is inferior to X-ray in clinical severe osteoporosis
  34. Fine-tuned ATP signals are acute mediators in osteocyte mechanotransduction
  35. Perceived age is associated with bone status in women aged 25–93 years
  36. Is allopurinol use associated with an excess risk of osteoporotic fracture? A National Prescription Registry study
  37. The Influence of Clinical Experience and Photographic Presentation on Age Assessment of Women
  38. Serum 25-hydroxyvitamin D and self-reported mental health status in adult Danes
  39. A Reverse J-Shaped Association Between Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study
  40. Response to the letter by Grant
  41. Association between leukocyte telomere length and bone mineral density in women 25–93years of age
  42. Screening for celiac disease in Danish adults
  43. The PRIMARA study to review cinacalcet use in patients with primary hyperparathyroidism
  44. Muscle strength, power and cardiorespiratory fitness are associated with bone mineral density in men aged 31–60 years
  45. A review of lifestyle, smoking and other modifiable risk factors for osteoporotic fractures
  46. Epidemiology of forearm fractures in adults in Denmark: national age- and gender-specific incidence rates, ratio of forearm to hip fractures, and extent of surgical fracture repair in inpatients and outpatients
  47. Genetic variants in theP2RX7gene are associated with risk of multiple myeloma
  48. Non-infectious osteomyelitis of the mandible in a young woman: a case report
  49. Status of drug development for the prevention and treatment of osteoporosis
  50. The P2X7 Receptor: A Key Player in Immune-Mediated Bone Loss?
  51. UTP-induced ATP release is a fine-tuned signalling pathway in osteocytes
  52. The effect of PTH(1-34) on fracture healing during different loading conditions
  53. A Standardized Vascular Disease Health Check in Europe: A Cost-Effectiveness Analysis
  54. Purinergic Signaling in Bone
  55. Low levels of vitamin D are associated with increased mortality in patients attending a university hospital in Denmark
  56. Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status
  57. Clopidogrel (Plavix), a P2Y12receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo
  58. Gastrointestinal Events with Clopidogrel: A Nationwide Population-Based Cohort Study
  59. Short-term teriparatide treatment does not affect NT-proBNP, a marker of cardiac disease
  60. Use of the oral platelet inhibitors dipyridamole and acetylsalicylic acid is associated with increased risk of fracture
  61. A Reverse J-Shaped Association of All-Cause Mortality with Serum 25-Hydroxyvitamin D in General Practice: The CopD Study
  62. Association of P2X7 receptor polymorphisms with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients
  63. Association of P2Y2 receptor SNPs with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients
  64. Secondary hyperparathyroidism and mortality in hip fracture patients compared to a control group from general practice
  65. Elevated liver enzymes, anaemia and osteopaenia in a young woman
  66. Paget's disease of the bone after treatment with Denosumab: A case report
  67. Clopidogrel and the risk of osteoporotic fractures: a nationwide cohort study
  68. Determinants of vitamin D status in a general population of Danish adults
  69. Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures
  70. Effects of Increasing Age, Dosage, and Duration of PTH Treatment on BMD Increase—A Meta-analysis
  71. Association between P2X7 Receptor Polymorphisms and Bone Status in Mice
  72. Genetic Background Strongly Influences the Bone Phenotype of P2X7 Receptor Knockout Mice
  73. Clinical and biochemical outcomes of cinacalcet treatment of familial hypocalciuric hypercalcemia: a case series
  74. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans
  75. Effects of Anti-osteoporosis Medications on Fracture Healing
  76. Role of purinergic receptor polymorphisms in human bone
  77. The Evidence for Efficacy of Osteoporosis Treatment in Men with Primary Osteoporosis: A Systematic Review and Meta-Analysis of Antiresorptive and Anabolic Treatment in Men
  78. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution
  79. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
  80. Effect of a program of multifactorial fall prevention on health-related quality of life, functional ability, fear of falling and psychological well-being. A randomized controlled trial
  81. Parathyroid Hormone and Bone Healing
  82. Amylin(1–8) is Devoid of Anabolic Activity in Bone
  83. Glucocorticoid Induced Osteopenia in Cancellous Bone of Sheep
  84. Baseline and Follow-Up Characteristics of Participants and Nonparticipants in a Randomized Clinical Trial of Multifactorial Fall Prevention in Denmark
  85. An Outpatient Multifactorial Falls Prevention Intervention Does Not Reduce Falls in High-Risk Elderly Danes
  86. Protein-containing nutrient supplementation following strength training enhances the effect on muscle mass, strength, and bone formation in postmenopausal women
  87. Osteoporosis in chronic obstructive pulmonary disease patients
  88. Primary and Secondary Prophylaxis to the Use of Inhaled Glucocorticoid in Primary Health Care
  89. Mechanical Muscle Function, Morphology, and Fiber Type in Lifelong Trained Elderly
  90. Effects of treatment with fluoride on bone mineral density and fracture risk - a meta-analysis
  91. Tendon collagen synthesis at rest and after exercise in women
  92. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease—A cross sectional study
  93. Management of risk of glucocorticoid-induced osteoporosis due to systemic administration in general practice in Denmark
  94. Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk – a meta-analysis
  95. MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men—results from the Odense Androgen Study
  96. No effect of menstrual cycle on myofibrillar and connective tissue protein synthesis in contracting skeletal muscle
  97. Calcium-Sensing Receptor Induces Proliferation through p38 Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase But Not Extracellularly Regulated Kinase in a Model of Humoral Hypercalcemia of Malignancy
  98. Editorial
  99. Calcium-Sensing Receptor Induces Messenger Ribonucleic Acid of Human Securin, Pituitary Tumor Transforming Gene, in Rat Testicular Cancer
  100. Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells
  101. The calcium-sensing receptor in human disease
  102. Rapid suppression of S-PTH by oral calcitriol and calcium in healthy premenopausal women
  103. Serum levels of parathyroid hormone and markers of bone metabolism in patients with rheumatoid arthritis. Relationship to disease activity and glucocorticoid treatment
  104. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism associated with mutations in the human Ca2+-sensing receptor gene in three Danish families
  105. The Vitamin D Receptor (VDR) Start Codon Polymorphism in Primary Hyperparathyroidism and Parathyroid VDR Messenger Ribonucleic Acid Levels1
  106. Evidence for a role of intracellular stored parathyroid hormone in producing hysteresis of the PTH–calcium relationship in normal humans
  107. Effect of nasal salmon calcitonin on posttraumatic osteopenia following ankle fracture: A randomized double-blind placebo-controlled study in 24 patients
  108. A mathematical/physiological model of parathyroid hormone secretion in response to blood-ionized calcium loweringin vivo
  109. Parathyroid hormone secretion in chronic renal failure
  110. Inter-relations between the calcium set-points of Parfitt and Brown in primary hyperparathyroidism: a sequential citrate and calcium clamp study
  111. Cica-clamp technique: a method for quantifying parathyroid hormone secretion: a sequential citrate and calcium clamp study
  112. Changing incidence and residual lifetime risk of common osteoporosis-related fractures
  113. Radial and humeral fractures as predictors of subsequent hip, radial or humeral fractures in women, and their seasonal variation
  114. Normal pattern of parathyroid response to blood calcium lowering in primary hyperparathyroidism: a citrate clamp study
  115. Induced hypocalcaemia and intact PTH responsiveness in patients with primary hyperparathyroidism, primary hypoparathyroidism and normal man
  116. Calcium clamp technique: Suppression of serum intact PTH by induced hypercalcaemia in normal man and primary hyperparathyroidism
  117. Induced hypocalcaemia controlled by a citrate clamp technique, and the intact parathyroid hormone response obtained